Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia
Anthony J. Roecker, Christopher D. Cox, Paul J. Coleman
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 2, pp. 504-530
Closed Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

G protein-coupled receptors: structure- and function-based drug discovery
Dehua Yang, Qingtong Zhou, Viktorija Labroska, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 419
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Mingyang Zhang, Ting Chen, Xun Lu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 100
Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies
Elena Urrestarazu, Jorge Iriarte
Nature and Science of Sleep (2016), pp. 21-21
Open Access | Times Cited: 102
Seven-membered N-heterocycles as approved drugs and promising leads in medicinal chemistry as well as the metal-free domino access to their scaffolds
Aleksandra Leśniewska, Piotr Przybylski
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116556-116556
Open Access | Times Cited: 9
An Update on Dual Orexin Receptor Antagonists and Their Potential Role in Insomnia Therapeutics
Kayla Janto, J. Roxanne Prichard, Snigdha Pusalavidyasagar
Journal of Clinical Sleep Medicine (2018) Vol. 14, Iss. 08, pp. 1399-1408
Open Access | Times Cited: 81
The Impact of Chemical Probes in Drug Discovery: A Pharmaceutical Industry Perspective
R. M. Garbaccio, Emma R. Parmee
Cell chemical biology (2016) Vol. 23, Iss. 1, pp. 10-17
Open Access | Times Cited: 80
Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis
Mathieu Rappas, A. Ali, K.A. Bennett, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 4, pp. 1528-1543
Open Access | Times Cited: 65
Effects of Suvorexant, a Dual Orexin/Hypocretin Receptor Antagonist, on Impulsive Behavior Associated with Cocaine
Taylor A. Gentile, Steven J. Simmons, Mia N. Watson, et al.
Neuropsychopharmacology (2017) Vol. 43, Iss. 5, pp. 1001-1009
Open Access | Times Cited: 64
Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases
Alain Couvineau, Thierry Voisin, Pascal Nicole, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 63
Cyclic tailor-made amino acids in the design of modern pharmaceuticals
Jiang Liu, Jianlin Han, Kunisuke Izawa, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112736-112736
Closed Access | Times Cited: 57
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19
New drug approvals for 2022: Synthesis and clinical applications
Shuo Yuan, Dandan Shen, Rui Jia, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 2352-2391
Closed Access | Times Cited: 18
Structure-based development of a subtype-selective orexin 1 receptor antagonist
Jan Hellmann, Matthäus Drabek, Jie Yin, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 30, pp. 18059-18067
Open Access | Times Cited: 46
Plants Alkaloids Based Compound as Therapeutic Potential for Neurodegenerative
Rajnish Kumar Patel, Dushyant Gangwar, Harsh K. Gupta, et al.
Journal for Research in Applied Sciences and Biotechnology (2023) Vol. 2, Iss. 2, pp. 14-26
Open Access | Times Cited: 14
The present and future of synthetic orexin receptor agonists
Tsuyoshi Saitoh, Takeshi Sakurai
Peptides (2023) Vol. 167, pp. 171051-171051
Open Access | Times Cited: 13
Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer’s disease and Parkinson’s disease: Therapeutic avenue of Dual OXR Antagonist (DORA)
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access
The hypocretin/orexin system in sleep disorders: preclinical insights and clinical progress
Michelle Cao, Matthew Chow
Nature and Science of Sleep (2016), pp. 81-81
Open Access | Times Cited: 38
The Orexin receptors: Structural and anti-tumoral properties
Alain Couvineau, Pascal Nicole, Valérie Gratio, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 20
Orexin Receptor Antagonists and Insomnia
Xin Wu, Tao Xue, Zhouqing Chen, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 10, pp. 509-521
Closed Access | Times Cited: 20
Synthesis of Tetrahydroisoquinoline Alkaloids and Related Compounds through the Alkylation of Anodically Prepared α-Amino Nitriles
Lotfi Benmekhbi, Fadila Louafi, Thierry Roisnel, et al.
The Journal of Organic Chemistry (2016) Vol. 81, Iss. 15, pp. 6721-6739
Closed Access | Times Cited: 38
Metabolic signals in sleep regulation: recent insights
Radhika Basheer, Charu Shukla
Nature and Science of Sleep (2016), pp. 9-9
Open Access | Times Cited: 37
Design and Synthesis of Potent and Highly Selective Orexin 1 Receptor Antagonists with a Morphinan Skeleton and Their Pharmacologies
Hiroshi Nagase, Naoshi Yamamoto, Masahiro Yata, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 3, pp. 1018-1040
Closed Access | Times Cited: 34
Highly Regioselective Radical Transformation of N-Sulfonyl-1,2,3-triazoles in Air
Zi Li, Qinghua Wei, Longlong Song, et al.
Organic Letters (2019) Vol. 21, Iss. 16, pp. 6413-6417
Closed Access | Times Cited: 34
The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role
Alain Couvineau, Stéphanie Dayot, Pascal Nicole, et al.
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 32
Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists
Dehui� Zhang, David A. Perrey, Ann M. Decker, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 8806-8825
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top